The evolution of drug-resistant malaria

Trans R Soc Trop Med Hyg. 2009 Apr;103 Suppl 1(Suppl 1):S11-4. doi: 10.1016/j.trstmh.2008.11.002. Epub 2008 Dec 12.

Abstract

Molecular epidemiological investigations have uncovered the patterns of emergence and global spread of Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine. Malaria parasites highly resistant to chloroquine and pyrimethamine spread from Asian origins to Africa, at great cost to human health and life. If artemisinin-resistant falciparum malaria follows the same pattern, renewed efforts to eliminate and eradicate malaria will be gravely threatened. This paper, adapted from a talk given in honour of Professor Malcolm Molyneux in Liverpool in September 2008, reviews the rise and fall of clinically important forms of drug-resistant falciparum malaria and considers how lessons learned from studying the evolution of drug-resistant malaria can be applied to efforts to prevent and deter resistance.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa / epidemiology
  • Antimalarials / pharmacology*
  • Chloroquine / pharmacology*
  • Drug Combinations
  • Drug Resistance* / genetics
  • Evolution, Molecular
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / prevention & control
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / genetics
  • Pyrimethamine / pharmacology*
  • Sulfadoxine / pharmacology*

Substances

  • Antimalarials
  • Drug Combinations
  • fanasil, pyrimethamine drug combination
  • Sulfadoxine
  • Chloroquine
  • Pyrimethamine